Showing results (41-50 of 652) with videos related to

Sort By:
Pageof 66
Current Opinion in Drug Discovery & Development|April 3, 2003
Development of vaccines against self-antigens: the p53 paradigmSunil Chada, Abner Mhashilkar, Jack A Roth, et al.
Cancer Research|July 10, 2007
Tumor suppressor 101F6 and ascorbate synergistically and selectively inhibit non-small cell lung cancer growth by caspase-independent apoptosis and autophagyShoichiro Ohtani, Arifumi Iwamaru, Wuguo Deng, et al.
Scientific Reports|November 16, 2016
TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug AuranofinCao Xiaobo, Mourad Majidi, Meng Feng, et al.
Oncotarget|January 4, 2018
TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)Xiaobo Cao, Yang Zhao, Jing Wang, et al.
Scientific Reports|August 24, 2017
A miR-SNP biomarker linked to an increased lung cancer survival by miRNA-mediated down-regulation of FZD4 expression and Wnt signalingJing Lin, Roza Zandi, Ruping Shao, et al.
Cancer Biology & Therapy|September 29, 2009
High level of AKT activity is associated with resistance to MEK inhibitor AZD6244 (ARRY-142886)Jieru Meng, Henry Peng, Bingbing Dai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2002
Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivoTapas Mukhopadhyay, Ji-ichiro Sasaki, Rajagopal Ramesh, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 6, 2010
Adenovirus-mediated interleukin (IL)-24 immunotherapy for cancerRajagopal Ramesh, Constantine G Ioannides, Jack A Roth, et al.
Cancer Research|October 5, 2006
The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatin-induced resistance in human non-small-cell lung cancer cellsKentaro Ueda, Hiroyuki Kawashima, Shoichiro Ohtani, et al.
Gynecologic Oncology|September 28, 2005
The nude rat as an orthotopic model for cervical cancerKatsuyuki Hamada, Norifumi Ueda, Masaharu Ito, et al.
Pageof 66